Skip to content

Differences in biological responses between open and closed system cardiopulmonary bypass for adult cardiac surgery

Differences in biological responses between open and closed system cardiopulmonary bypass for adult cardiac surgery - Biological responses after usage of open and closed system cardiopulmonary bypass

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022227
Enrollment
24
Registered
2016-05-09
Start date
2015-05-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valvular heart disease requiring valve replacement or valve plasty

Interventions

A total 24 patients consist of the study population. These 24 patients are prospectively divided into the CS-CPB group and OS-CPB group in double blind fashion. Then, the patients will undergo cardiac
white blood cell, hemoglobin, hematocrit, platelet, serum creatinine, serum AST, serum ALT. Length of postoperative mechanical ventilation, ICU stay, occurrence of AKI, and intraoperative bleeding are

Sponsors

Saitama Medical Center, Jichi Medical University, Department of Cardiovascular Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who undergo elective cardiac valve surgery in the Saitama Medical Center, Jichi Medical University, Saitama, Japan

Exclusion criteria

Exclusion criteria: 1) patients aged 49 years or younger 2) patients aged 76 years or older 3) patients who undergo surgical concomitant coronary artery revascularization or thoracic aortic surgery 4) patients who have preoperative liver dysfunction (AST > 30 IU/l and ALT > 30 IU/l) 5) patients who have chronic kidney diseae (serum creatinine level > 2.0mg/dl) 6) patients who have autoimmune disease 7) patients who are treated with steroid or other immune suppressing drug 8) patients who have blood disorder 9) patients in whom preoperative informed consent is difficult 10)patients who have decreased left ventricular function (left ventricular ejection fraction < 40%)

Design outcomes

Primary

MeasureTime frame
1. length of ICU stay 2. length of postoperative mechanical ventilation

Secondary

MeasureTime frame
1. postoperative WBC count 2. postoperaitve hemoglobin and hematocrit 3. postoperative serum creatinine 4. postoperative serum ASL/ALT (1-4;maximum value within 2 days of surgery) 5. postoperative acute kidney injury (assessed with AKIN classification) 6. intraoperative bleeding

Countries

Japan

Contacts

Public ContactNaoyuki Kimura

Saitama Medical Center, Jichi Medical University Cardiovascular Surgery

kimura-n@omiya.jichi.ac.jp+81-48-647-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026